Stevanato Group STVN
$15.65 −$0.28 (-1.76%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $15.65 0.00%
Open$15.90
Prev close$15.93
Day range$15.35 – $16.15
Volume752.3K
Market cap$4.27B
P/E (TTM)28.0
Dividend yield0.39%
STVN Stock News
Headlines matching Stevanato Group or the STVN ticker, most recent first.
- William Blair Maintains Stevanato Group(STVN.US) With Buy Rating
- BofA Securities Maintains Stevanato Group(STVN.US) With Buy Rating
- Morgan Stanley Maintains Stevanato Group(STVN.US) With Hold Rating, Raises Target Price to $20 Positive
- TD Cowen Maintains Stevanato Group(STVN.US) With Buy Rating, Maintains Target Price $25
- Earnings Flash (STVN) Stevanato Posts Q2 Adjusted EPS 0.14 Euros, Vs. FactSet Est of 0.13 Euros
- Analysts Have Conflicting Sentiments on These Healthcare Companies: Oculis Holding (OCS), Stevanato Group (STVN) and Structure Therapeutics, Inc. Sponsored ADR (GPCR)
- Citi Maintains Stevanato Group(STVN.US) With Buy Rating, Maintains Target Price $26
- TD Cowen Initiates Stevanato Group(STVN.US) With Buy Rating, Announces Target Price $25
- Wolfe Research Initiates Stevanato Group(STVN.US) With Buy Rating, Announces Target Price $21
- TD Cowen Initiates Stevanato Group(STVN.US) With Buy Rating, Announces Target Price $28.97
- Morgan Stanley Maintains Stevanato Group(STVN.US) With Hold Rating, Maintains Target Price $19
- Morgan Stanley Maintains Stevanato Group(STVN.US) With Hold Rating, Cuts Target Price to $18.28 Negative
- William Blair Maintains Stevanato Group(STVN.US) With Buy Rating, Raises Target Price to $17.5 Positive
- Morgan Stanley Maintains Stevanato Group(STVN.US) With Hold Rating, Cuts Target Price to $19 Negative
- Citi Maintains Stevanato Group(STVN.US) With Buy Rating, Cuts Target Price to $26 Negative
No comments yet — be the first to weigh in on STVN.
Sign in to join the discussion.